Phase I Study of Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer
Phase of Trial: Phase I
Latest Information Update: 06 Nov 2019
Price : $35 *
At a glance
- Drugs Epacadostat (Primary) ; Capecitabine; Oxaliplatin
- Indications Rectal cancer
- Focus Adverse reactions
- 31 Oct 2019 Planned End Date changed from 30 Apr 2023 to 31 May 2023.
- 31 Oct 2019 Planned primary completion date changed from 30 Apr 2023 to 31 May 2023.
- 31 Oct 2019 Status changed from not yet recruiting to recruiting.